Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,954 | -5,964 | -26,582 | -21,101 | -13,802 |
| Depreciation Amortization | 45 | 23 | 119 | 91 | 61 |
| Accounts receivable | -80 | -46 | -129 | -127 | -3 |
| Other Working Capital | -90 | -1,037 | 2,339 | 2,114 | 589 |
| Other Operating Activity | 1,474 | 237 | 4,472 | 3,730 | 2,767 |
| Operating Cash Flow | $-13,605 | $-6,787 | $-19,782 | $-15,293 | $-10,388 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 70,741 | 8,233 | -3,527 | -3,263 | -2,371 |
| Investing Cash Flow | $70,741 | $8,233 | $-3,527 | $-3,263 | $-2,371 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 807 | 163 | N/A | N/A | N/A |
| Common Stock Repurchased | 33 | 33 | 69 | 50 | 50 |
| Other Financing Activity | 0 | 0 | -137 | -105 | -69 |
| Financing Cash Flow | $840 | $197 | $-68 | $-55 | $-19 |
| Exchange Rate Effect | 5 | 0 | 3 | 1 | 2 |
| Beginning Cash Position | 33,702 | 33,702 | 57,077 | 57,077 | 57,077 |
| End Cash Position | 91,683 | 35,345 | 33,702 | 38,467 | 44,301 |
| Net Cash Flow | $57,981 | $1,643 | $-23,375 | $-18,610 | $-12,776 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,605 | -6,787 | -19,782 | -15,293 | -10,388 |
| Free Cash Flow | -13,605 | -6,787 | -19,782 | -15,293 | -10,388 |